+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Impact of COVID-19 on Pharmaceutical Social Media Influencer Activity

  • ID: 5119011
  • Report
  • June 2020
  • Region: Global
  • 90 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
Summary

The highly contagious coronavirus (SARS-CoV-2), dubbed COVID-19 (formerly 2019-nCoV), which emerged at the close of 2019, has led to a medical emergency across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020.

This report analyzes the publisher's social media Influencer dashboards to understand Influencer trends since the pandemic began and what key Influencers are discussing online about COVID-19.

This report analyzes Influencer trends since the pandemic began and what assesses what key Influencers are discussing online about the virus.

Scope

The report includes 10 Influencers -
  • Eight therapy areas: Cardiovascular, Metabolic Disorders, Immunology, Infectious Diseases, Neurology, Oncology, Ophthalmology, and Biosimilars
  • Digital Pharma
  • Macroeconomics
Reasons to Buy
  • View Influencer trends across different therapy areas and themes since the COVID-19 pandemic began.
  • Stay up to date on what key Influencers are discussing online about the virus.
  • Identify key Influencers across therapy areas and themes.
Note: Product cover images may vary from those shown
2 of 2
Impact of COVID-19 on Social Media Influencers
  • Cardiovascular
  • Metabolic Disorders
  • Immunology
  • Infectious Diseases
  • Neurology
  • OncologyOphthalmology
  • Digital Pharma
  • Macroeconomic Influencers
Appendix
  • Abbreviations
  • Methodology
  • Related Reports
  • About the Authors
  • About the Publisher
Note: Product cover images may vary from those shown
Adroll
adroll